0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Haloperidol Decanoate API Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-23I13757
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Haloperidol Decanoate API Market Research Report 2023
BUY CHAPTERS

Global Haloperidol Decanoate API Market Research Report 2025

Code: QYRE-Auto-23I13757
Report
May 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Haloperidol Decanoate API Market Size

The global market for Haloperidol Decanoate API was valued at US$ 584 million in the year 2024 and is projected to reach a revised size of US$ 776 million by 2031, growing at a CAGR of 4.2% during the forecast period.

Haloperidol Decanoate API Market

Haloperidol Decanoate API Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Haloperidol Decanoate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haloperidol Decanoate API.
The Haloperidol Decanoate API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Haloperidol Decanoate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Haloperidol Decanoate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Haloperidol Decanoate API Market Report

Report Metric Details
Report Name Haloperidol Decanoate API Market
Accounted market size in year US$ 584 million
Forecasted market size in 2031 US$ 776 million
CAGR 4.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Purity≥99%
  • Purity<99%
Segment by Application
  • Injection
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company JANSSEN PHARMACEUTICA NV, TEVA PHARMACEUTICAL INDUSTRIES LTD, OLON SPA, MSN LIFE SCIENCES PRIVATE LTD, MANKIND PHARMA LTD
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Haloperidol Decanoate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Haloperidol Decanoate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Haloperidol Decanoate API Market growing?

Ans: The Haloperidol Decanoate API Market witnessing a CAGR of 4.2% during the forecast period 2025-2031.

What is the Haloperidol Decanoate API Market size in 2031?

Ans: The Haloperidol Decanoate API Market size in 2031 will be US$ 776 million.

Who are the main players in the Haloperidol Decanoate API Market report?

Ans: The main players in the Haloperidol Decanoate API Market are JANSSEN PHARMACEUTICA NV, TEVA PHARMACEUTICAL INDUSTRIES LTD, OLON SPA, MSN LIFE SCIENCES PRIVATE LTD, MANKIND PHARMA LTD

What are the Application segmentation covered in the Haloperidol Decanoate API Market report?

Ans: The Applications covered in the Haloperidol Decanoate API Market report are Injection, Others

What are the Type segmentation covered in the Haloperidol Decanoate API Market report?

Ans: The Types covered in the Haloperidol Decanoate API Market report are Purity≥99%, Purity<99%

Recommended Reports

API Market Reports

Neuro & Psych APIs

Additional Pharma APIs

1 Haloperidol Decanoate API Market Overview
1.1 Product Definition
1.2 Haloperidol Decanoate API by Type
1.2.1 Global Haloperidol Decanoate API Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Haloperidol Decanoate API by Application
1.3.1 Global Haloperidol Decanoate API Market Value by Application (2024 VS 2031)
1.3.2 Injection
1.3.3 Others
1.4 Global Haloperidol Decanoate API Market Size Estimates and Forecasts
1.4.1 Global Haloperidol Decanoate API Revenue 2020-2031
1.4.2 Global Haloperidol Decanoate API Sales 2020-2031
1.4.3 Global Haloperidol Decanoate API Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Haloperidol Decanoate API Market Competition by Manufacturers
2.1 Global Haloperidol Decanoate API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Haloperidol Decanoate API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Haloperidol Decanoate API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Haloperidol Decanoate API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Haloperidol Decanoate API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Haloperidol Decanoate API, Product Type & Application
2.7 Global Key Manufacturers of Haloperidol Decanoate API, Date of Enter into This Industry
2.8 Global Haloperidol Decanoate API Market Competitive Situation and Trends
2.8.1 Global Haloperidol Decanoate API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Haloperidol Decanoate API Players Market Share by Revenue
2.8.3 Global Haloperidol Decanoate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Haloperidol Decanoate API Market Scenario by Region
3.1 Global Haloperidol Decanoate API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Haloperidol Decanoate API Sales by Region: 2020-2031
3.2.1 Global Haloperidol Decanoate API Sales by Region: 2020-2025
3.2.2 Global Haloperidol Decanoate API Sales by Region: 2026-2031
3.3 Global Haloperidol Decanoate API Revenue by Region: 2020-2031
3.3.1 Global Haloperidol Decanoate API Revenue by Region: 2020-2025
3.3.2 Global Haloperidol Decanoate API Revenue by Region: 2026-2031
3.4 North America Haloperidol Decanoate API Market Facts & Figures by Country
3.4.1 North America Haloperidol Decanoate API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Haloperidol Decanoate API Sales by Country (2020-2031)
3.4.3 North America Haloperidol Decanoate API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Haloperidol Decanoate API Market Facts & Figures by Country
3.5.1 Europe Haloperidol Decanoate API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Haloperidol Decanoate API Sales by Country (2020-2031)
3.5.3 Europe Haloperidol Decanoate API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Haloperidol Decanoate API Market Facts & Figures by Region
3.6.1 Asia Pacific Haloperidol Decanoate API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Haloperidol Decanoate API Sales by Region (2020-2031)
3.6.3 Asia Pacific Haloperidol Decanoate API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Haloperidol Decanoate API Market Facts & Figures by Country
3.7.1 Latin America Haloperidol Decanoate API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Haloperidol Decanoate API Sales by Country (2020-2031)
3.7.3 Latin America Haloperidol Decanoate API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Haloperidol Decanoate API Market Facts & Figures by Country
3.8.1 Middle East and Africa Haloperidol Decanoate API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Haloperidol Decanoate API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Haloperidol Decanoate API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Haloperidol Decanoate API Sales by Type (2020-2031)
4.1.1 Global Haloperidol Decanoate API Sales by Type (2020-2025)
4.1.2 Global Haloperidol Decanoate API Sales by Type (2026-2031)
4.1.3 Global Haloperidol Decanoate API Sales Market Share by Type (2020-2031)
4.2 Global Haloperidol Decanoate API Revenue by Type (2020-2031)
4.2.1 Global Haloperidol Decanoate API Revenue by Type (2020-2025)
4.2.2 Global Haloperidol Decanoate API Revenue by Type (2026-2031)
4.2.3 Global Haloperidol Decanoate API Revenue Market Share by Type (2020-2031)
4.3 Global Haloperidol Decanoate API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Haloperidol Decanoate API Sales by Application (2020-2031)
5.1.1 Global Haloperidol Decanoate API Sales by Application (2020-2025)
5.1.2 Global Haloperidol Decanoate API Sales by Application (2026-2031)
5.1.3 Global Haloperidol Decanoate API Sales Market Share by Application (2020-2031)
5.2 Global Haloperidol Decanoate API Revenue by Application (2020-2031)
5.2.1 Global Haloperidol Decanoate API Revenue by Application (2020-2025)
5.2.2 Global Haloperidol Decanoate API Revenue by Application (2026-2031)
5.2.3 Global Haloperidol Decanoate API Revenue Market Share by Application (2020-2031)
5.3 Global Haloperidol Decanoate API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 JANSSEN PHARMACEUTICA NV
6.1.1 JANSSEN PHARMACEUTICA NV Company Information
6.1.2 JANSSEN PHARMACEUTICA NV Description and Business Overview
6.1.3 JANSSEN PHARMACEUTICA NV Haloperidol Decanoate API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 JANSSEN PHARMACEUTICA NV Haloperidol Decanoate API Product Portfolio
6.1.5 JANSSEN PHARMACEUTICA NV Recent Developments/Updates
6.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
6.2.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Company Information
6.2.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Description and Business Overview
6.2.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Haloperidol Decanoate API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Haloperidol Decanoate API Product Portfolio
6.2.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
6.3 OLON SPA
6.3.1 OLON SPA Company Information
6.3.2 OLON SPA Description and Business Overview
6.3.3 OLON SPA Haloperidol Decanoate API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 OLON SPA Haloperidol Decanoate API Product Portfolio
6.3.5 OLON SPA Recent Developments/Updates
6.4 MSN LIFE SCIENCES PRIVATE LTD
6.4.1 MSN LIFE SCIENCES PRIVATE LTD Company Information
6.4.2 MSN LIFE SCIENCES PRIVATE LTD Description and Business Overview
6.4.3 MSN LIFE SCIENCES PRIVATE LTD Haloperidol Decanoate API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MSN LIFE SCIENCES PRIVATE LTD Haloperidol Decanoate API Product Portfolio
6.4.5 MSN LIFE SCIENCES PRIVATE LTD Recent Developments/Updates
6.5 MANKIND PHARMA LTD
6.5.1 MANKIND PHARMA LTD Company Information
6.5.2 MANKIND PHARMA LTD Description and Business Overview
6.5.3 MANKIND PHARMA LTD Haloperidol Decanoate API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MANKIND PHARMA LTD Haloperidol Decanoate API Product Portfolio
6.5.5 MANKIND PHARMA LTD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Haloperidol Decanoate API Industry Chain Analysis
7.2 Haloperidol Decanoate API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Haloperidol Decanoate API Production Mode & Process Analysis
7.4 Haloperidol Decanoate API Sales and Marketing
7.4.1 Haloperidol Decanoate API Sales Channels
7.4.2 Haloperidol Decanoate API Distributors
7.5 Haloperidol Decanoate API Customer Analysis
8 Haloperidol Decanoate API Market Dynamics
8.1 Haloperidol Decanoate API Industry Trends
8.2 Haloperidol Decanoate API Market Drivers
8.3 Haloperidol Decanoate API Market Challenges
8.4 Haloperidol Decanoate API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Haloperidol Decanoate API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Haloperidol Decanoate API Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Haloperidol Decanoate API Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Haloperidol Decanoate API Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Haloperidol Decanoate API Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Haloperidol Decanoate API Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Haloperidol Decanoate API Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Haloperidol Decanoate API Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Haloperidol Decanoate API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Haloperidol Decanoate API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Haloperidol Decanoate API, Product Type & Application
 Table 12. Global Key Manufacturers of Haloperidol Decanoate API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Haloperidol Decanoate API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haloperidol Decanoate API as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Haloperidol Decanoate API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Haloperidol Decanoate API Sales by Region (2020-2025) & (Tons)
 Table 18. Global Haloperidol Decanoate API Sales Market Share by Region (2020-2025)
 Table 19. Global Haloperidol Decanoate API Sales by Region (2026-2031) & (Tons)
 Table 20. Global Haloperidol Decanoate API Sales Market Share by Region (2026-2031)
 Table 21. Global Haloperidol Decanoate API Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Haloperidol Decanoate API Revenue Market Share by Region (2020-2025)
 Table 23. Global Haloperidol Decanoate API Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Haloperidol Decanoate API Revenue Market Share by Region (2026-2031)
 Table 25. North America Haloperidol Decanoate API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Haloperidol Decanoate API Sales by Country (2020-2025) & (Tons)
 Table 27. North America Haloperidol Decanoate API Sales by Country (2026-2031) & (Tons)
 Table 28. North America Haloperidol Decanoate API Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Haloperidol Decanoate API Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Haloperidol Decanoate API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Haloperidol Decanoate API Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Haloperidol Decanoate API Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Haloperidol Decanoate API Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Haloperidol Decanoate API Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Haloperidol Decanoate API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Haloperidol Decanoate API Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Haloperidol Decanoate API Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Haloperidol Decanoate API Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Haloperidol Decanoate API Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Haloperidol Decanoate API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Haloperidol Decanoate API Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Haloperidol Decanoate API Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Haloperidol Decanoate API Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Haloperidol Decanoate API Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Haloperidol Decanoate API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Haloperidol Decanoate API Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Haloperidol Decanoate API Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Haloperidol Decanoate API Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Haloperidol Decanoate API Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Haloperidol Decanoate API Sales (Tons) by Type (2020-2025)
 Table 51. Global Haloperidol Decanoate API Sales (Tons) by Type (2026-2031)
 Table 52. Global Haloperidol Decanoate API Sales Market Share by Type (2020-2025)
 Table 53. Global Haloperidol Decanoate API Sales Market Share by Type (2026-2031)
 Table 54. Global Haloperidol Decanoate API Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Haloperidol Decanoate API Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Haloperidol Decanoate API Revenue Market Share by Type (2020-2025)
 Table 57. Global Haloperidol Decanoate API Revenue Market Share by Type (2026-2031)
 Table 58. Global Haloperidol Decanoate API Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Haloperidol Decanoate API Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Haloperidol Decanoate API Sales (Tons) by Application (2020-2025)
 Table 61. Global Haloperidol Decanoate API Sales (Tons) by Application (2026-2031)
 Table 62. Global Haloperidol Decanoate API Sales Market Share by Application (2020-2025)
 Table 63. Global Haloperidol Decanoate API Sales Market Share by Application (2026-2031)
 Table 64. Global Haloperidol Decanoate API Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Haloperidol Decanoate API Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Haloperidol Decanoate API Revenue Market Share by Application (2020-2025)
 Table 67. Global Haloperidol Decanoate API Revenue Market Share by Application (2026-2031)
 Table 68. Global Haloperidol Decanoate API Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Haloperidol Decanoate API Price (US$/Ton) by Application (2026-2031)
 Table 70. JANSSEN PHARMACEUTICA NV Company Information
 Table 71. JANSSEN PHARMACEUTICA NV Description and Business Overview
 Table 72. JANSSEN PHARMACEUTICA NV Haloperidol Decanoate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. JANSSEN PHARMACEUTICA NV Haloperidol Decanoate API Product
 Table 74. JANSSEN PHARMACEUTICA NV Recent Developments/Updates
 Table 75. TEVA PHARMACEUTICAL INDUSTRIES LTD Company Information
 Table 76. TEVA PHARMACEUTICAL INDUSTRIES LTD Description and Business Overview
 Table 77. TEVA PHARMACEUTICAL INDUSTRIES LTD Haloperidol Decanoate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. TEVA PHARMACEUTICAL INDUSTRIES LTD Haloperidol Decanoate API Product
 Table 79. TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
 Table 80. OLON SPA Company Information
 Table 81. OLON SPA Description and Business Overview
 Table 82. OLON SPA Haloperidol Decanoate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. OLON SPA Haloperidol Decanoate API Product
 Table 84. OLON SPA Recent Developments/Updates
 Table 85. MSN LIFE SCIENCES PRIVATE LTD Company Information
 Table 86. MSN LIFE SCIENCES PRIVATE LTD Description and Business Overview
 Table 87. MSN LIFE SCIENCES PRIVATE LTD Haloperidol Decanoate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. MSN LIFE SCIENCES PRIVATE LTD Haloperidol Decanoate API Product
 Table 89. MSN LIFE SCIENCES PRIVATE LTD Recent Developments/Updates
 Table 90. MANKIND PHARMA LTD Company Information
 Table 91. MANKIND PHARMA LTD Description and Business Overview
 Table 92. MANKIND PHARMA LTD Haloperidol Decanoate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. MANKIND PHARMA LTD Haloperidol Decanoate API Product
 Table 94. MANKIND PHARMA LTD Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Haloperidol Decanoate API Distributors List
 Table 98. Haloperidol Decanoate API Customers List
 Table 99. Haloperidol Decanoate API Market Trends
 Table 100. Haloperidol Decanoate API Market Drivers
 Table 101. Haloperidol Decanoate API Market Challenges
 Table 102. Haloperidol Decanoate API Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Haloperidol Decanoate API
 Figure 2. Global Haloperidol Decanoate API Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Haloperidol Decanoate API Market Share by Type: 2024 & 2031
 Figure 4. Purity≥99% Product Picture
 Figure 5. Purity<99% Product Picture
 Figure 6. Global Haloperidol Decanoate API Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Haloperidol Decanoate API Market Share by Application: 2024 & 2031
 Figure 8. Injection
 Figure 9. Others
 Figure 10. Global Haloperidol Decanoate API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Haloperidol Decanoate API Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Haloperidol Decanoate API Sales (2020-2031) & (Tons)
 Figure 13. Global Haloperidol Decanoate API Average Price (US$/Ton) & (2020-2031)
 Figure 14. Haloperidol Decanoate API Report Years Considered
 Figure 15. Haloperidol Decanoate API Sales Share by Manufacturers in 2024
 Figure 16. Global Haloperidol Decanoate API Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Haloperidol Decanoate API Players: Market Share by Revenue in Haloperidol Decanoate API in 2024
 Figure 18. Haloperidol Decanoate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Haloperidol Decanoate API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Haloperidol Decanoate API Sales Market Share by Country (2020-2031)
 Figure 21. North America Haloperidol Decanoate API Revenue Market Share by Country (2020-2031)
 Figure 22. United States Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Haloperidol Decanoate API Sales Market Share by Country (2020-2031)
 Figure 25. Europe Haloperidol Decanoate API Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Haloperidol Decanoate API Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Haloperidol Decanoate API Revenue Market Share by Region (2020-2031)
 Figure 33. China Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Haloperidol Decanoate API Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Haloperidol Decanoate API Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Haloperidol Decanoate API Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Haloperidol Decanoate API Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Haloperidol Decanoate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Haloperidol Decanoate API by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Haloperidol Decanoate API by Type (2020-2031)
 Figure 52. Global Haloperidol Decanoate API Price (US$/Ton) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Haloperidol Decanoate API by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Haloperidol Decanoate API by Application (2020-2031)
 Figure 55. Global Haloperidol Decanoate API Price (US$/Ton) by Application (2020-2031)
 Figure 56. Haloperidol Decanoate API Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS